ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Zivo Bioscience, Inc.

Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025

$6.80+0.30 (+4.62%)

Close on Oct 19, 2026

Community

Notes and questions about Zivo Bioscience from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Zivo Bioscience's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-6 reverse split on Oct 27, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ZIVO.

Operating margin-4045.7% · median -4762.2%

Net margin-4059.7% · median -4366.4%

Advertisement
300 × 250